A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1. BUSINESS Teleflex Incorporated is referred to herein as “we,” “us,” “our,” “Teleflex” and the “Company.” THE COMPANY Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We market and sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Because our products are used in numerous markets and for a variety of procedures, we are not dependent upon any one end-market or procedure. Our major manufacturing operations are located in the Czech Republic, Malaysia, Mexico and the United States (the "U.S.").
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.0B | 2.0B | 1.7B | 1.7B | 2.8B | 2.8B |
| Net Income | -906M | -906M | 70M | 356M | 363M | 485M |
| EPS | $-20.25 | $-20.25 | $1.48 | $7.53 | $7.68 | $10.23 |
| Free Cash Flow | 1.4M | 1.4M | 211M | 160M | 264M | 581M |
| ROIC | 1.7% | 2.1% | 1.8% | 3.5% | 7.6% | 10.2% |
| Gross Margin | 56.2% | 56.2% | 61.0% | 60.7% | 54.9% | 55.2% |
| Debt/Equity | 0.87 | 0.87 | 0.41 | 0.43 | 0.46 | 0.52 |
| Dividends/Share | $1.35 | $1.36 | $1.36 | $1.36 | $1.36 | $1.36 |
| Operating Income | 118M | 118M | 104M | 259M | 500M | 628M |
| Operating Margin | 5.9% | 5.9% | 6.1% | 15.1% | 17.9% | 22.4% |
| ROE | -29.0% | -24.5% | 1.6% | 8.4% | 9.3% | 13.7% |
| Shares Outstanding | 45M | 45M | 47M | 47M | 47M | 47M |
TELEFLEX INC passes 4 of 9 quality checks, suggesting mixed fundamentals.
The company's 5-year average ROIC is 5.0% with a gross margin of 57.6%. Total shareholder yield (dividends + buybacks) is 6.4%. At current prices, the estimated annualized return to fair value is -7.7%.
TELEFLEX INC (TFX) has a 5-year average return on invested capital (ROIC) of 5.0%. This is below average and may indicate limited pricing power.
TELEFLEX INC (TFX) has a market capitalization of $5.6B. It is classified as a mid-cap stock.
Yes, TELEFLEX INC (TFX) pays a dividend with a trailing twelve-month yield of 1.08%. The company also returns capital through share buybacks, with a buyback yield of 5.36%.
TELEFLEX INC (TFX) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
TELEFLEX INC (TFX) reported annual revenue of $2.0 billion in its most recent fiscal year, based on SEC EDGAR filings.
TELEFLEX INC (TFX) has a net profit margin of -45.4%. The company is currently unprofitable.
TELEFLEX INC (TFX) generated $1 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
TELEFLEX INC (TFX) has a debt-to-equity ratio of 0.87. This indicates moderate leverage.
TELEFLEX INC (TFX) reported earnings per share (EPS) of $-20.25 in its most recent fiscal year.
TELEFLEX INC (TFX) has a return on equity (ROE) of -24.5%. A negative ROE may indicate losses or negative equity.
TELEFLEX INC (TFX) has a 5-year average gross margin of 57.6%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for TELEFLEX INC (TFX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
TELEFLEX INC (TFX) has a book value per share of $69.87, based on its most recent annual SEC filing.
No recent press releases.